Innovative Measurement of Physiological Function

The ClearView System

The ClearView System is a non-invasive electrophysiological measurement system that is designed specifically for use on the fingertips. The technology evokes photon images from the fingertips and those light images are captured by a camera and then processed by proprietary software. The information generated is presented in easy to understand report to be used to sustain and offer general improvement to conditions and functions associated with a general state of health.

The ClearView System, designed as a diagnostic device, is not available for sale at this time. The system is currently under consideration by the FDA as a de novo classification.


E-pic samples


ClearView System in Clinical Studies

Clinical Research Overview

EPIC Research and Diagnostics is committed to providing innovative solutions for the early stage recognition of diseases affecting the body, preventive care of patients, and assessing therapeutic effectiveness. This commitment includes conducting clinical research studies that can improve the way providers diagnose, treat and prevent diseases. Our specialized studies have provided reliable, statistically significant results that allow us to develop our products for future clinical use.

Clinical Trial History

Topic: Cardiovascular/Endocrine/GI/Respiratory/Hepatic/Renal
Protocol: GBMC Prognostic Indicators as Provided by the ClearView System
Study Duration: Sept 2010-Aug 2011
Study Site: Greater Baltimore Medical Center IRB, Baltimore, MD

Topic: Cardiovascular
Protocol: EPIC-001 Evaluation of Patients in Chest Pain in the Emergency Room
Study Duration: Sept 2011-June 2013
Study Site: Scottsdale Healthcare Hospital, Scottsdale, AZ
IRB: Scottsdale Healthcare Local IRB

Topic: Cardiovascular
Protocol: EPIC-006 Evaluation Using Clearview in Determining Association to the Cardiac Risk Factors
Study Duration: Nov 2012-Aug 2013
Study Site: Mission Internal Medical Group, Mission Viejo, CA
IRB: New England IRB

Topic: Metabolic Syndrome
Protocol: EPIC-009 Metabolic Feasibility Study
Study Duration: November 2014 – June 2015
Study Site: Integrative Health Institute, Scottsdale, AZ
IRB: Quorum IRB

Topic: Traumatic Brain Injury
Protocol: EPIC-011 TBI Feasibility Study
Study Duration: April 2014
Study Sites: University of Iowa
IRB: University of Iowa IRB

Topic: Venous Thromboembolism
Protocol: EPIC-013 VTE Feasibility Study
Study Duration: Study not initiated yet
Study Sites: Kansas University Medical Center, Kansas City, KS; SHARP Memorial Hospital, San Diego, CA

Topic: Breast Cancer
Protocol: EPIC-014 Breast Biopsy Feasibility Study
Study Duration: July 2015
Study Site: Southwest Surgery, Lake Havasu City, AZ
IRB: Quorum IRB